MedPath

ATORVASTATIN CALCIUM

These highlights do not include all the information needed to use CALCIUM TABLETS safely and effectively. See full prescribing information for CALCIUM TABLETS. CALCIUM tablets, for oral administration Initial U.S. Approval: 1996

Approved
Approval ID

fdfba989-7618-44ec-9ce1-8bff97c4a646

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 12, 2016

Manufacturers
FDA

Liberty Pharmaceuticals, Inc.

DUNS: 012568840

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ATORVASTATIN CALCIUM

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0440-7128
Application NumberANDA090548
Product Classification
M
Marketing Category
C73584
G
Generic Name
ATORVASTATIN CALCIUM
Product Specifications
Route of AdministrationORAL
Effective DateAugust 12, 2016
FDA Product Classification

INGREDIENTS (11)

CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SODIUM CARBONATEInactive
Code: 45P3261C7T
Classification: IACT
CALCIUM ACETATEInactive
Code: Y882YXF34X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
HYDROXYPROPYL CELLULOSE (TYPE H)Inactive
Code: RFW2ET671P
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATEActive
Quantity: 80 mg in 1 1
Code: YRZ789OWMI
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.